Anthony E. Fiore < Anthony E. Lang < Anthony F. Verow

Facettes :

List of bibliographic references indexed by Anthony E. Lang

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000013 (2013)	Margarita Pondal [Canada] ; Connie Marras [Canada] ; Janis Miyasaki [Canada] ; Elena Moro [Canada] ; Melissa J. Armstrong [Canada] ; Antonio P. Strafella [Canada] ; Binit B. Shah [Canada] ; Susan Fox [Canada] ; L K Prashanth [Canada] ; Nicolas Phielipp [Canada] ; Anthony E. Lang [Canada]	Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic
000048 (2012)	Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger	A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants
000131 (2011)	Christine Klein [Canada, Allemagne] ; Rosalind Chuang [Canada] ; Connie Marras [Canada] ; Anthony E. Lang [Canada]	The curious case of phenocopies in families with genetic Parkinson's disease
000139 (2011)	Kazutaka Kobayashi [États-Unis, Japon] ; Anthony E. Lang [Canada] ; Mark Hallett [États-Unis] ; Frederick A. Lenz [États-Unis]	Thalamic neuronal and EMG activity in psychogenic dystonia compared with organic dystonia
000186 (2011)	Connie Marras [Canada] ; Michael P. Mcdermott [États-Unis] ; Ken Marek [États-Unis] ; Paula Rochon [Canada] ; Gary Naglie [Canada] ; Caroline M. Tanner [États-Unis] ; Alice Rudolph [États-Unis] ; Ira Shoulson [États-Unis] ; Anthony E. Lang [Canada]	Predictors of time to requiring dopaminergic treatment in 2 Parkinson's disease cohorts
000208 (2011)	Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas]	Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials
000292 (2011)	Valerie Voon [Royaume-Uni] ; Mandy Sohr [Allemagne] ; Anthony E. Lang [Canada] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Jacqueline Whetteckey [États-Unis] ; Daniel Weintraub [États-Unis] ; Glen R. Wunderlich [Canada] ; Mark Stacy [États-Unis]	Impulse control disorders in parkinson disease: A multicenter case–control study
000379 (2011)	Robert D. Altman [Canada] ; Anthony E. Lang [Canada] ; Ronald B. Postuma [Canada]	Caffeine in Parkinson's disease: A pilot open‐label, dose‐escalation study
000416 (2011)	Anthony E. Lang [Canada]	A critical appraisal of the premotor symptoms of Parkinson's disease: Potential usefulness in early diagnosis and design of neuroprotective trials
000515 (2010)	Shen-Yang Lim [Canada, Malaisie] ; Anthony E. Lang [Canada]	The nonmotor symptoms of Parkinson's disease—An overview
000536 (2010)	Jerrold L. Vitek [États-Unis] ; Kelly E. Lyons [États-Unis] ; Roy Bakay [États-Unis] ; Alim-Louis Benabid [France] ; Guenther Deuschl [Allemagne] ; Mark Hallett [États-Unis] ; Roger Kurlan [États-Unis] ; Joseph J. Pancrazio [États-Unis] ; Ali Rezai [États-Unis] ; Benjamin L. Walter [États-Unis] ; Anthony E. Lang [Canada]	Standard guidelines for publication of deep brain stimulation studies in Parkinson's disease (Guide4DBS‐PD)
000655 (2010)	Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Pierre Pollak [France] ; Yves Agid [France] ; Stig Rehncrona [Suède] ; Jens Volkmann [Allemagne] ; Jaime Kulisevsky [Espagne] ; Jose A. Obeso [Espagne] ; Alberto Albanese [Italie] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Niall P. Quinn [Royaume-Uni] ; Jans D. Speelman [Pays-Bas] ; Alim-Louis Benabid [France] ; Valerie Fraix [France] ; Alexandre Mendes [France] ; Marie-Laure Welter [France] ; Jean-Luc Houeto [France] ; Philippe Cornu [France] ; Didier Dormont [France] ; Annalena L. Tornqvist [Suède] ; Ron Ekberg [Suède] ; Alfons Schnitzler [Allemagne] ; Lars Timmermann [Allemagne] ; Lars Wojtecki [Allemagne] ; Andres Gironell [Espagne] ; Maria C. Rodriguez-Oroz [Espagne] ; Jorge Guridi [Espagne] ; Anna R. Bentivoglio [Italie] ; Maria F. Contarino [Italie, Pays-Bas] ; Luigi Romito [Italie] ; Massimo Scerrati [Italie] ; Marc Janssens [Pays-Bas] ; Anthony E. Lang [Canada]	Long‐term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
000665 (2010)	Zhen Ni [Canada] ; Andrew D. Pinto [Canada] ; Anthony E. Lang [Canada] ; Robert Chen [Canada]	Involvement of the cerebellothalamocortical pathway in Parkinson disease
000668 (2010)	Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [Italie, États-Unis]	Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: The STRIDE‐PD study
000738 (2010)	Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas]	Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
000790 (2010)	Steven R. Schwid [États-Unis] ; Janice Bausch [États-Unis] ; David Oakes [États-Unis] ; Lynn Schuchter [États-Unis] ; Caroline Tanner [États-Unis] ; Misser Forrest [Danemark] ; Anthony E. Lang [Canada] ; Ira Shoulson [États-Unis]	Cancer incidence in a trial of an antiapoptotic agent for Parkinson's disease
000821 (2010)	Daniel Weintraub [États-Unis] ; Mandy Sohr [Allemagne] ; Marc N. Potenza [États-Unis] ; Andrew D. Siderowf [États-Unis] ; Mark Stacy [États-Unis] ; Valerie Voon [Royaume-Uni] ; Jacqueline Whetteckey [États-Unis] ; Glen R. Wunderlich [Canada] ; Anthony E. Lang [Canada]	Amantadine use associated with impulse control disorders in Parkinson disease in cross‐sectional study
000844 (2010)	Anette Schrag [Royaume-Uni] ; Shamira Sheikh [Royaume-Uni] ; Niall P. Quinn [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Caroline Selai [Royaume-Uni] ; Chris Mathias [Royaume-Uni] ; Irene Litvan [États-Unis] ; Anthony E. Lang [Canada] ; James H. Bower [États-Unis] ; David J. Burn [Royaume-Uni] ; Philip Low [États-Unis] ; Marjan Jahanshahi [Royaume-Uni]	A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy
000955 (2009)	Benedicte Ballanger [Canada] ; Thilo Van Eimeren [Canada] ; Elena Moro [Canada] ; Andres M. Lozano [Canada] ; Clement Hamani [Canada] ; Philippe Boulinguez [France] ; Giovanna Pellecchia [Canada] ; Sylvain Houle [Canada] ; Yu Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada]	Stimulation of the subthalamic nucleus and impulsivity: Release your horses
000A70 (2009)	Christine Klein [Allemagne, Canada] ; Susanne A. Schneider [Allemagne, Royaume-Uni] ; Anthony E. Lang [Canada]	Hereditary parkinsonism: Parkinson disease look‐alikes—An algorithm for clinicians to “PARK” genes and beyond
000B09 (2009)	C. Warren Olanow [États-Unis] ; Jeffrey H. Kordower [États-Unis] ; Anthony E. Lang [Canada] ; Jose A. Obeso [Espagne]	Dopaminergic transplantation for parkinson's disease: Current status and future prospects

---

List of associated KwdEn.i

Nombre de documents	Descripteur
29	Parkinson's disease
7	deep brain stimulation
5	subthalamic nucleus
3	dyskinesia
3	levodopa
2	depression
2	dopamine agonist
2	neuroprotection
2	partial dopamine agonist
2	plasticity
2	ropinirole
2	treatment
1	Abbreviations: CS = conditioned stimulus; DNS = digital nerve stimulation; FDI = first dorsal interosseus; ISI = interstimulus interval; LAI = long latency afferent inhibition; LICI = long interval intracortical inhibition; MEP = motor evoked potential; MNS = median nerve stimulation; SAI = short latency afferent inhibition; SEP = somatosensory evoked potential; TMS = transcranial magnetic stimulation; TS = test stimulus; UPDRS = Unified Parkinson’s Disease Rating Scale
1	Brazil
1	G2919S
1	Health‐related quality of life
1	Keywords: Parkinson’s disease, motor cortex, magnetic stimulation, nerve stimulation
1	LRRK
1	L‐dopa
1	Melanoma
1	PARK
1	PSP, MSA
1	Parkin
1	Parkinson
1	Rating scale
1	SF‐36.
1	SPECT
1	UPDRS
1	Validity
1	animal models
1	antipsychotics
1	anxiety
1	apoptosis
1	assessment
1	basal ganglia
1	biomarker
1	break point analysis
1	caffeine
1	cancer
1	central pain
1	classification
1	clinical trials
1	contraindications
1	delayed auditory feedback
1	distribution
1	dopamine
1	dopamine D2 receptors
1	dopamine transporter
1	dopa‐responsive dystonia
1	dystonia
1	dystonia‐related activity
1	exon rearrangements
1	functional magnetic resonance imaging
1	genetic testing
1	genetics
1	globus pallidus internus
1	health status
1	human thalamus
1	imaging
1	indications
1	levodopa response
1	linkage analysis
1	linkage disequilibrium
1	long‐term benefit
1	masking noise
1	meta‐analysis
1	monotherapy
1	motor complications
1	movement disorders
1	multiple system atrophy
1	multiplex ligation‐dependent probe amplification
1	mutation
1	myoclonus‐dystonia
1	neural circuitry
1	neuronal activity
1	nondopaminergic
1	nonmotor
1	non‐motor
1	olfaction
1	organic dystonia
1	origin
1	outcome
1	pardoprunox
1	pardoprunox (SLV308)
1	parkinsonian pain
1	parkinsonism
1	pathological gambling
1	pharmacology
1	phenocopy
1	predictive factors
1	premotor
1	prognosis
1	progression
1	progressive supranuclear palsy
1	psychogenic dystonia
1	psychosis
1	publication guidelines
1	quality of life
1	randomized controlled clinical trial
1	randomized controlled trial

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Anthony E. Lang" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Anthony E. Lang" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Anthony E. Lang
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024